About Us
Careers
Partner with us
Forgot password?
Sign in
Login
Login
Email
Password
Forgot your password?
Join VuMedi
Select specialty
Your main specialty
Adult & Family Medicine
Allergy, Asthma, Immunology
Anesthesiology
Cardiovascular
Dental
Dermatology
Emergency Medicine
Endocrinology
Gastroenterology & Hepatology
General Surgery
Hematology & Oncology
Infectious Disease
Medical Genetics
Nephrology
Neurology
Neurosurgery
Obstetrics/Gynecology
Ophthalmology
Oral Maxillofacial
Orthopaedics
Otolaryngology
Pathology
Pediatrics
Physical Medicine & Rehab
Plastic Surgery
Podiatry
Preventive Medicine
Psychiatry
Pulmonology
Radiation Oncology
Radiology
Rheumatology
Urology
First name
Last name
Email
Choose Password
Playback speed
0.5x
0.75x
1x (Normal)
1.25x
1.5x
1.75x
2x
10 seconds
Current Challenges in Lipid Lowering Therapy and Prevention of ASCVD
By
Michael Shapiro
7 Videos
979 views
August 18, 2017
0 Comments
Login to view comments.
Click here to Login
Webinar
Update on PCSK9 Inhibitors Webinar
11:55
Michael Shapiro
Current Challenges in Lipid Lowering Therapy and Prevention of ASCVD
16:05
Seth Martin
Science of PCSK9 and LDL-C Lowering Efficacy
18:24
Stephen Kopecky
CV Outcomes Trials with PCSK9 Inhibitors – SPIRE, ODYSSEY, FOURIER a…
13:46
Seth Baum
Barriers to Accessing PCSK9 Inhibitors
16:13
Michael Shapiro
Update on PCSK9 Inhibitors Discussion
VuMedi Webinars
Update on PCSK9 Inhibitors
Thumbs Up
390 views
August 18, 2017